Adherium Ltd (AU:ADR) — Market Cap & Net Worth
Market Cap & Net Worth: Adherium Ltd (ADR)
Adherium Ltd (AU:ADR) has a market capitalization of $7.37 Million (AU$10.42 Million) as of May 6, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27548 globally and #1434 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adherium Ltd's stock price AU$0.00 by its total outstanding shares 5210900326 (5.21 Billion). Analyse cash flow conversion of Adherium Ltd to see how efficiently the company converts income to cash.
Adherium Ltd Market Cap History: 2015 to 2026
Adherium Ltd's market capitalization history from 2015 to 2026. Data shows change from $34.05 Billion to $7.37 Million (-55.23% CAGR).
Adherium Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adherium Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
22.56x
Adherium Ltd's market cap is 22.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $12.67 Billion | $2.10 Million | -$6.31 Million | 6030.76x | N/A |
| 2017 | $5.28 Billion | $2.35 Million | -$12.81 Million | 2249.30x | N/A |
| 2018 | $1.95 Billion | $5.87 Million | -$9.34 Million | 332.95x | N/A |
| 2019 | $1.48 Billion | $2.78 Million | -$11.79 Million | 531.89x | N/A |
| 2020 | $1.48 Billion | $2.22 Million | -$11.40 Million | 666.43x | N/A |
| 2021 | $580.71 Million | $401.00K | -$15.04 Million | 1448.15x | N/A |
| 2022 | $211.27 Million | $529.00K | -$10.04 Million | 399.37x | N/A |
| 2023 | $197.26 Million | $3.19 Million | -$9.86 Million | 61.74x | N/A |
| 2024 | $51.62 Million | $840.98K | -$10.22 Million | 61.38x | N/A |
| 2025 | $18.44 Million | $817.24K | -$12.68 Million | 22.56x | N/A |
Competitor Companies of ADR by Market Capitalization
Companies near Adherium Ltd in the global market cap rankings as of May 6, 2026.
Key companies related to Adherium Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #146 globally with a market cap of $151.58 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #206 globally with a market cap of $112.99 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #228 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #245 globally with a market cap of $99.91 Billion USD ( €85.46 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #146 | Abbott Laboratories | NYSE:ABT | $151.58 Billion | $87.17 |
| #206 | Stryker Corporation | NYSE:SYK | $112.99 Billion | $295.25 |
| #228 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #245 | Medtronic PLC | XETRA:2M6 | $99.91 Billion | €66.56 |
Adherium Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Adherium Ltd's market cap moved from $34.05 Billion to $ 7.37 Million, with a yearly change of -55.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$7.37 Million | -60.00% |
| 2025 | AU$18.44 Million | -64.29% |
| 2024 | AU$51.62 Million | -73.83% |
| 2023 | AU$197.26 Million | -6.63% |
| 2022 | AU$211.27 Million | -63.62% |
| 2021 | AU$580.71 Million | -60.71% |
| 2020 | AU$1.48 Billion | 0.00% |
| 2019 | AU$1.48 Billion | -24.33% |
| 2018 | AU$1.95 Billion | -63.00% |
| 2017 | AU$5.28 Billion | -58.33% |
| 2016 | AU$12.67 Billion | -62.79% |
| 2015 | AU$34.05 Billion | -- |
End of Day Market Cap According to Different Sources
On May 6th, 2026 the market cap of Adherium Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.37 Million USD |
| MoneyControl | $7.37 Million USD |
| MarketWatch | $7.37 Million USD |
| marketcap.company | $7.37 Million USD |
| Reuters | $7.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more